Janus Henderson Investors
JHG
Performance
About Janus Henderson Investors
Janus Henderson Investors is a global investment management company that helps individuals and institutions invest in a better future. With a 90-year history, the company provides disciplined investments and world-class service to its clients.
Recent News
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
JPMorgan, Barclays, Fifth Third Sued by Investors for Missing ‘Giant Red Flags’ at Tricolor
The Biden Fiduciary Rule Is Officially Dead. What Comes Next?
Jana Partners Takes 5% Stake in Alkami Technology
The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start
“Three-Year Hump”: Janus Henderson Asia CEO Warns of “Musical Chairs” In Frothy Talent Market
Multiliquid, Metalayer Launch Instant Redemption Backstop for RWAs on Solana
JAAA: Superior Risk-Adjusted Return Presents Unique Buying Opportunity
Millennium Hires Former JPMorgan Credit Trader in London
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
Standard Life’s Briggs Warns ‘Retirement Adequacy Is a Genuine Concern’, as £2bn Aegon Deal Unveiled
How to De-Risk Your Portfolio in 5 Different Scenarios
King Street Wins Saudi Backing for New Middle East-Focused Private Credit Fund
Munis Steady, New-Issue Calendar Grows to $13.5B
Caldera Therapeutics Launches with $112.5M in Total Capital
Janus Henderson Calls for Defensive Carry in Multi‑Sector Credit Amid Middle East Conflict
Software Stocks See Worst Start to Year Since 2022 as AI Disruption Fears Mount
The Week’s 10 Biggest Funding Rounds: Security And Energy Deals Top The List
BlossomHill Therapeutics Inks $84M Series B Extension
Citadel’s Global Fixed Income Strategy Hit by March Market Turmoil
Think Bioscience Raises $55M Series A
Inflation Goes up by a Whopping Monthly Rate of Nearly 1%—And It’s Hitting You at the Grocery Store and Gas Station
New Frontier In The Gulf
CesiumAstro to Scale Operations with $470 Million in Equity and Debt Financing
Recent Deals
CesiumAstro Raises $470M in Growth Capital, CEO Sabripour Calls It a ‘Scale Moment’
Think Bioscience Secures $55M Series A Funding
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
BlossomHill Therapeutics Secures $84M Series B Extension Funding
Parabilis Medicines Secures $305M Series F Funding Led by RA Capital, Fidelity Management, and Janus Henderson
Ambrosia Biosciences Secures $100M Series B Funding
BlossomHill Therapeutics Secures $84M Series B Extension
